期刊文献+

BEP方案治疗高危耐药性妊娠滋养细胞肿瘤37例临床分析 被引量:5

暂未订购
导出
摘要 目的探讨博莱霉素(BLM)、依托泊苷(VP-16)及顺铂(DDP)联合化疗(BEP方案)治疗高危耐药性妊娠滋养细胞肿瘤(rrGTN)的可行性。方法回顾性分析接受BEP方案化疗的37例rrGTN患者的临床资料,随访36例,1例失访。观察疗效、不良反应及继发性肿瘤的情况,并关注34例保留生育功能患者的妊娠结局。结果 37例rrGTN中初治高危GTN 18例,耐药19例。其中3例辅以全子宫切除术,2例辅以双侧子宫动脉化疗栓塞术。化疗总疗程为168个,平均为4.54个疗程;化疗后34例完全缓解,临床治愈率91.89%;所有存活患者无继发性肿瘤发生。不良反应分别为:骨髓抑制37例(100%),消化道反应20例(54.1%),脱发14例(37.8%),一过性肝酶升高8例(21.6%),一过性血尿素氯升高4例(10.8%),皮疹2例(5.4%),均有效处理,未影响化疗。保留生育功能的34例中共获8例次妊娠,包括人工流产2例次,妊娠中期引产1例次,足月分娩5例次;5例新生儿无先天性畸形。结论应用BEP方案治疗rrGTN安全、有效,是治疗rrGTN的理想化疗方案。
出处 《山东医药》 CAS 2013年第44期77-79,共3页 Shandong Medical Journal
  • 相关文献

参考文献14

  • 1Ngan HY. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia [ J . Int J Gynecol Cancer, 2004,14 ( 2 ) : 202-205.
  • 2Lurain JR, Singh DK, Schink JC. Role of surgery in the manage- ment of high-risk gestational trophoblast ic neoplasia[ J]. J ReprodMed, 2006,51 (10) :773- 776.
  • 3Suzuka K, Matsui H, Iitsuka Y, et al. Adjuvant hysterectomy in low-risk gestational trophoblastic disease [ J ]. Obstet Gynecol, 2001,97 ( 3 ) :431-434.
  • 4雷呈志,向阳.滋养细胞肿瘤动脉化疗的临床应用[J].实用妇产科杂志,2006,22(8):456-458. 被引量:13
  • 5李彩霞,张凯,谢富波.选择性子宫动脉化疗栓塞治疗难治性妊娠滋养细胞肿瘤[J].山东大学学报(医学版),2011,49(12):136-138. 被引量:4
  • 6Schecter NR, Mychalczak B, Jones W, et al. Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease[ J]. Gynecol Oncol, 1998,68 (2) : 183-192.
  • 7Feng F, Xiang Y, Li L. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy -re- sistant gestational trophoblastic neoplasia [ J ]. Gynecol Oncol, 2009,113(3) :312-315.
  • 8Matsui H, Suzuka K, Yamazawa K, et al. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy [ J ]. Gynecol Oncol, 2005,96 ( 3 ) :616 - 620.
  • 9Turan T, Karacay O, Tulunay G, et al. Results with EMA/CO ( etoposide, methotrexate, actinomycin D, cyclophosphamide, vin- cristine) chemotherapy in gestational trophoblastic neoplasia [ J ]. Int J Gynecol Cancer, 2006,16 (3) : 1432-1438.
  • 10Alifrangis C, Agarwal R, Short D, et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis [ J ]. J Clin On- col, 2013,31 (2) :280-286.

二级参考文献4

共引文献15

同被引文献66

  • 1万希润,向阳,杨秀玉,吴郁,刘宁,陈玲,董若凡.FAEV化疗方案治疗高危型耐药性妊娠滋养细胞肿瘤的疗效分析[J].中华妇产科杂志,2006,41(2):88-90. 被引量:11
  • 2蒋华,刘燕文,姜维美.顺铂的时辰化疗[J].肿瘤防治研究,2007,34(9):714-715. 被引量:25
  • 3吴江,袁志敏,林晓辉,余海清,张岚,庞世权.顺铂时辰给药合并羟基喜树碱治疗晚期非小细胞肺癌的临床观察[J].肿瘤防治研究,2007,34(11):877-880. 被引量:5
  • 4龙邦,刘福坤.循证肿瘤治疗学[M].郑州大学出版社,2004.299,806-812.
  • 5Almon RR, Yang E, Lai W, et al. Circadian variations in rat liver gene expression: relationships to drug actions[J]. J Pharmacol Exp Ther, 2008, 326(3): 700-716.
  • 6Berkowitz RS, Horowitz NS, Goldstein DP. Gestational trophoblastic disease :pre-sentations from the XVIhh World Congress on Gesta- tional Trophoblastic Diseases[ J]. J Reprod Med, 2014,59 ( 5-6 ) : 187.
  • 7Lurain JR. Gestational trophoblastic disease II:classification and management of gestational trophoblastic neoplasia [ J 1 Am J Obstet Gynecol,2011,204( 1 ) : 11-18. DOI: 10. 1016/j. ajog. 2010.06. 072.
  • 8Osborne ILl, Filiaci V, Schink JC, et al. Phase II1 trial of weekly methotre-xate or pulsed daetinomycin for low -risk gestational trophoblastie neoplasia : a gynecologic oneology grotlp study [ J ]. J Clin Oncol, 2011,29 ( 7 ) :825-831. DOI : 10. 1200/JCO. 2010.30. 4386.
  • 9Peng M, Ding Y, Yu L, et al. Tegafur Substitution for 5-Fu in Com- bination with Aetinomyein D to Treat Gestational Tmphoblasfic Ne- oplasm [ J ]. PLoS One ,2015,10 ( 11 ) : e0143531. DOI: 10. 1371/ journal, pone. 0143531.
  • 10Ngan HY, Seekl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease [ J ]. Int J Gy- necol Obstet,2015,131 Suppl2 :$123-$126. DOI : 10. 1016/j. ijgo. 2015.06. 008.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部